• 专利标题:   Modified graphene oxide for absorption of low abundance protein, is prepared by reacting carbon-containing solid with reactant in a solvent to form graphene oxide precursor which is dispersed along with polyethylene glycol and dehydrating agent, in aprotic solvent, in presence of catalyst.
  • 专利号:   CN114272909-A
  • 发明人:   HUANG Y, ZHOU S, WANG B
  • 专利权人:   CHINESE ACAD SCI GUANGZHOU CHEM RES INST, NANXIONG CAS INCUBATOR OPERATION CO LTD, SHAOGUAN TECH INNOVATION INCUBATION CE
  • 国际专利分类:   B01J020/26, B01J020/30, C07K001/14, C07K014/765, C07K014/805, G01N021/31
  • 专利详细信息:   CN114272909-A 05 Apr 2022 B01J-020/26 202283 Chinese
  • 申请详细信息:   CN114272909-A CN11039006 28 Sep 2020
  • 优先权号:   CN11039006

▎ 摘  要

NOVELTY - A polyethylene glycol modified graphene oxide is prepared by reacting a carbon-containing solid with a reactant in a solvent to form a graphene oxide precursor which is dispersed along with a polyethylene glycol substance and a dehydrating agent, in an aprotic solvent. The reaction is catalyzed by a catalyst. The reactant used is sulfur trioxide, chlorosulfonic acid, sulfur dioxide, sodium sulfite, sulfurous acid, peroxydisulfuric acid, ammonium persulfate and/or concentrated sulfuric acid. The solvent used is aqueous ammonia, toluene, xylene, anisole, concentrated sulfuric acid, 30 wt.% hydrogen peroxide solution, deionized water, methanol, ethanol, propanol, dichloromethane, N-dimethylformamide, N-dimethylacetamide, acetone, butanone, diethyl ether and/or tetrahydrofuran. The aprotic solvent used is dimethyl sulfoxide, N-dimethylformamide, N-dimethylacetamide, acetone, butanone, acetonitrile and/or tetrahydrofuran. USE - The polyethylene glycol-modified graphene oxide is used for adsorption of low abundance protein (claimed) in complex biological samples. The graphene oxide is also used in sample pretreatment in biology and medicine applications. ADVANTAGE - The polyethylene glycol modified graphene oxide prepared, has low agglomeration and improved dispersibility. The method is a stable and highly sensitive process which enables to prepare graphene oxide which has good performance in acid-base environments of most biological samples. The graphene oxide suitable for extracting and separating low-abundance proteins in complex biological samples, has efficiency in removing protein-pollutants in the biological samples. DETAILED DESCRIPTION - A polyethylene glycol modified graphene oxide is prepared by reacting a carbon-containing solid (A) with a reactant in a solvent to form a graphene oxide precursor which is dispersed along with a polyethylene glycol substance and a dehydrating agent, in an aprotic solvent, the reaction is catalyzed by a catalyst. The reactant used is sulfur trioxide, chlorosulfonic acid, sulfur dioxide, sodium sulfite, sulfurous acid, peroxydisulfuric acid, ammonium persulfate and/or concentrated sulfuric acid. The solvent used is aqueous ammonia, toluene, xylene, anisole, concentrated sulfuric acid, 30 wt.% hydrogen peroxide solution, deionized water, methanol, ethanol, propanol, dichloromethane, N-dimethylformamide, N-dimethylacetamide, acetone, butanone, diethyl ether and/or tetrahydrofuran. The aprotic solvent used is dimethyl sulfoxide, N-dimethylformamide, N-dimethylacetamide, acetone, butanone, acetonitrile and/or tetrahydrofuran. The catalyst used is cuprous bromide, cuprous chloride, cupric bromide, zinc chloride, sodium chloride, ferrous chloride, ferric chloride, aluminum chloride, boron trifluoride diethyl ether, boron trichloride, cobalt chloride, 4-dimethylaminopyridine, triethylamine, tetramethylethylenediamine and/or pentamethyl diethylenetriamine. An INDEPENDENT CLAIM is included for the production of polyethylene glycol-modified graphene oxide. DESCRIPTION OF DRAWING(S) - The drawing shows plot of sample A, sample B and sample C of polyethylene glycol-modified graphene oxide.